
New Gilead study in Science Translational Medicine: HIV can mutate to resist Lenacapavir, but the virus pays a high price. The M66I mutation reduces viral replication capacity to below 20%
Read more on: shorturl.at/7Dflb
#HIV #Lenacapavir #Gilead #Virology #Science
English
